VEGFA and myasthenia gravis: We have previously demonstrated significantly increased IL-15 and VEGF levels and significantly decreased IL-4 levels in patients with MG, in addition to a significant increase in IL-8, eotaxin, MIP-1α, MIP-1β and IL-1b levels in MG patients with thymoma3.